Horizon Scanning

It is a challenge for health plans and clinicians to know what emerging technologies are in the preapproval phase and what their clinical, financial, and risk impacts might be. This is where we come in.

The Hayes Horizon Scanning Solution identifies innovative and potentially disruptive health technologies that are in various stages of the regulatory approval process. Our Research Analysts continually investigate new technologies that are on the horizon or in the early stages of clinical investigation, as well as the testing of existing technologies that may be seeking approval for new clinical applications. Hayes Horizon Scanning helps you track emerging technologies before you need to make decisions. Accessed through the Hayes Knowledge Center, Hayes Horizon Scanning addresses the following fundamental questions to help our clients forecast emerging technologies:

  • Is this emerging technology new or replacing an existing technology?
  • Where is this technology in the FDA regulatory process?
  • When will this technology be commercially available in the market?
  • What is the projected use, cost, and financial impact of this technology?

DigiMatch™ Robodoc® System

A computer-assisted robotic surgical system and 3-D preoperative planning system used to prepare the joint cavity and bone surface for total hip and knee arthroplasty and assist in the selection of the appropriate joint implant.

Organ Care System™

An organ perfusion transport system designed to maintain a donor heart in a warm functioning state outside of the body during transport from organ donor to recipient.

Flibanserin (Possibly Girosa™)

An oral, serotonin 5-HT receptor agonist and a dopamine D4 receptor partial agonist proposed for the treatment of hypoactive sexual desire disorder in premenopausal women.

Krystexxa™ (Pegloticase)

An intravenous recombinant PEGylated formulation of porcine uricase for the treatment of chronic gout in patients with refractory disease or unable to tolerate current care therapy.

Doripenem (Doribax™)

An intravenous antibiotic in development for the treatment of nosocomial pneumonia, including ventilator-associated pneumonia.

CollaRx® Gentamicin Surgical Implant

A biodegradable collagen sponge impregnated with gentamicin and implanted during surgery for use as an adjunct to postoperative intravenous antibiotics for the prevention of surgical site infections.